Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Knight Therapeutics Inc. (KHTRF)

Compare
3.9500
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
371,304
371,304
328,199
293,563
243,478
Cost of Revenue
196,899
196,899
175,547
155,502
128,066
Gross Profit
174,405
174,405
152,652
138,061
115,412
Operating Expense
167,008
167,008
146,282
155,121
128,244
Operating Income
7,397
7,397
6,370
-17,060
-12,832
Net Non Operating Interest Income Expense
1,187
1,187
87
4,032
3,764
Other Income Expense
-6,532
-6,532
-28,445
-30,932
15,758
Pretax Income
2,052
2,052
-21,988
-43,960
6,690
Tax Provision
-2,280
-2,280
-5,153
-14,068
-8,985
Net Income Common Stockholders
4,332
4,332
-16,835
-29,892
15,675
Diluted NI Available to Com Stockholders
4,332
4,332
-16,835
-29,892
15,675
Basic EPS
0.04
--
-0.16
-0.26
0.13
Diluted EPS
0.04
--
-0.16
-0.26
0.13
Basic Average Shares
101,040.5810
--
107,465.9780
114,890.2520
124,480.2590
Diluted Average Shares
101,436.9020
--
107,465.9780
114,890.2520
124,521.6410
Total Operating Income as Reported
7,397
7,397
-2,890
-41,044
-12,832
Total Expenses
363,907
363,907
321,829
310,623
256,310
Net Income from Continuing & Discontinued Operation
4,332
4,332
-16,835
-29,892
15,675
Normalized Income
9,774.5500
9,774.5500
7,167.9675
-6,121.2400
4,186.9500
Interest Income
10,410
10,410
12,575
10,632
7,382
Interest Expense
9,223
9,223
12,488
6,600
3,618
Net Interest Income
1,187
1,187
87
4,032
3,764
EBIT
11,275
11,275
-9,500
-37,360
10,308
EBITDA
64,384
64,384
40,897
25,261
58,223
Reconciled Cost of Revenue
188,145
188,145
170,190
144,623
121,327
Reconciled Depreciation
53,109
53,109
50,397
62,621
47,915
Net Income from Continuing Operation Net Minority Interest
4,332
4,332
-16,835
-29,892
15,675
Total Unusual Items Excluding Goodwill
-6,403
-6,403
-31,350
-34,957
15,630
Total Unusual Items
-6,403
-6,403
-31,350
-34,957
15,630
Normalized EBITDA
70,787
70,787
72,247
60,218
42,593
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-960.4500
-960.4500
-7,347.0325
-11,186.2400
4,141.9500
12/31/2021 - 4/3/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade